Search research articles
Contact Us
Filters
Showing results (1-10 of 172) with videos related to
Page
of 18
Sort By:
The Journal of Urology
|
November 12, 2017
Editorial Comment
Alessandro Antonelli, Carlotta Palumbo
Annals of Translational Medicine
|
March 17, 2020
Below safety limits, every unit of glomerular filtration rate counts-reply letter
Carlotta Palumbo, Alessandro Antonelli
Current Opinion in Urology
|
April 14, 2025
Salvage treatment of local recurrence following radical and partial nephrectomy
Davide Perri, Carlotta Palumbo, Alessandro Volpe
Annals of Translational Medicine
|
October 29, 2019
Neoadjuvant androgen deprivation therapy through intense inhibition of the androgen target: "<i>Midsummer Night's Dream</i>" or "<i>Much Ado About Nothing</i>"?
Alessandro Antonelli, Carlotta Palumbo, Alfredo Berruti
The New England Journal of Medicine
|
April 26, 2013
Functional outcomes after treatment for prostate cancer
Bernardo Rocco, Elisa De Lorenzis, Carlotta Palumbo
European Urology Oncology
|
March 15, 2025
Stereotactic Radiation for Primary Renal Cell Carcinoma: Is It Ready for Prime Time?
Raquibul Hannan, Veronica Mollica, Carlotta Palumbo, et al.
Minerva Urology and Nephrology
|
February 11, 2022
Is active surveillance a safe option for small RCCs as it is for small renal masses?
Carlotta Palumbo, Angela Pecoraro, Davide Perri, et al.
European Urology Oncology
|
August 23, 2024
Can Sarcomatoid Features Guide the Use of Adjuvant Atezolizumab Following Nephrectomy? Probably Not
Eduard Roussel, Michele Marchioni, Carlotta Palumbo, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
October 14, 2014
Bladder tumours in children: An interesting case report of TCC with a partial inverted growth pattern
Davide Abed El Rahman, Giuseppe Salvo, Carlotta Palumbo, et al.
Minerva Urology and Nephrology
|
September 25, 2024
Adjuvant pembrolizumab prolongs overall survival in renal cell carcinoma at high-risk of recurrence after nephrectomy. Can we do better than this?
Chiara Ciccarese, Veronica Mollica, Laura Marandino, et al.
Page
of 18
Search research articles
Search
Showing results (1-10 of 172) with videos related to
Sort By:
Page
of 18
The Journal of Urology
|
November 12, 2017
Editorial Comment
Alessandro Antonelli, Carlotta Palumbo
Annals of Translational Medicine
|
March 17, 2020
Below safety limits, every unit of glomerular filtration rate counts-reply letter
Carlotta Palumbo, Alessandro Antonelli
Current Opinion in Urology
|
April 14, 2025
Salvage treatment of local recurrence following radical and partial nephrectomy
Davide Perri, Carlotta Palumbo, Alessandro Volpe
Annals of Translational Medicine
|
October 29, 2019
Neoadjuvant androgen deprivation therapy through intense inhibition of the androgen target: "<i>Midsummer Night's Dream</i>" or "<i>Much Ado About Nothing</i>"?
Alessandro Antonelli, Carlotta Palumbo, Alfredo Berruti
The New England Journal of Medicine
|
April 26, 2013
Functional outcomes after treatment for prostate cancer
Bernardo Rocco, Elisa De Lorenzis, Carlotta Palumbo
European Urology Oncology
|
March 15, 2025
Stereotactic Radiation for Primary Renal Cell Carcinoma: Is It Ready for Prime Time?
Raquibul Hannan, Veronica Mollica, Carlotta Palumbo, et al.
Minerva Urology and Nephrology
|
February 11, 2022
Is active surveillance a safe option for small RCCs as it is for small renal masses?
Carlotta Palumbo, Angela Pecoraro, Davide Perri, et al.
European Urology Oncology
|
August 23, 2024
Can Sarcomatoid Features Guide the Use of Adjuvant Atezolizumab Following Nephrectomy? Probably Not
Eduard Roussel, Michele Marchioni, Carlotta Palumbo, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
October 14, 2014
Bladder tumours in children: An interesting case report of TCC with a partial inverted growth pattern
Davide Abed El Rahman, Giuseppe Salvo, Carlotta Palumbo, et al.
Minerva Urology and Nephrology
|
September 25, 2024
Adjuvant pembrolizumab prolongs overall survival in renal cell carcinoma at high-risk of recurrence after nephrectomy. Can we do better than this?
Chiara Ciccarese, Veronica Mollica, Laura Marandino, et al.
Page
of 18